Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
SSX4B - SSX Family Member 4B
Alias:
CT5.4
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因的产物属于高度同源的滑膜肉瘤X(SSX)断裂蛋白家族。这些蛋白可能作为转录抑制因子发挥作用。它们还能在癌症患者中引发自发的体液和细胞免疫反应,并成为癌症疫苗基免疫治疗的潜在有用靶点。SSX1、SSX2和SSX4基因已参与t(X;18)易位,这是所有滑膜肉瘤的特征。这一易位导致染色体18上的滑膜肉瘤易位基因与染色体X上的一个SSX基因融合。染色体Xp11包含一个段性重复,导致滑膜肉瘤、X断裂点4、SSX4和SSX4B两个相同拷贝以尾对尾的取向存在。这个基因,SSX4B,代表了更着丝粒的拷贝。已发现这个基因的两个转录变异体,编码不同的异构体。[RefSeq,2008年7月提供]
Related ID:
NCBI:548313
ENSEMBL:ENSG00000269791
HGNC:16880
UNIPROT:O60224
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
548313
3
8
9879 bp
21.86
6
--
--
3
SSX4B Genetics information (-)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top